Foresite Capital Management IV, LLC
Position in LYEL — Lyell Immunopharma, Inc.
CIK 1704132
West Hollywood, CA
Position in LYEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,056,003
-$8,580,278 QoQ
Shares Held
800,399
0.0% QoQ
Ownership
3.27%
of shares outstanding
% of Portfolio
6.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Foresite Capital Management IV, LLC holds $290,151,347 across 6 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
4,778,581 | $165,243,330 | |
| 2 | CYTK |
Cytokinetics Inc
|
714,695 | $60,884,867 | |
| 3 | EIKN |
Eikon Therapeutics, Inc.
|
1,943,682 | $25,365,050 | |
| 4 | RLAY |
Relay Therapeutics, Inc.
|
1,250,000 | $23,387,500 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
160,000 | $9,657,600 | |
| 6 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
150,000 | $5,613,000 |
All Filings in LYEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,056,003 | 800,399 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,636,281 | 800,399 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,998,479 | 800,399 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,075,527 | 800,399 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,612,303 | 16,007,999 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,328,000 | 8,325,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,488,500 | 8,325,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,071,250 | 8,325,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $18,564,750 | 8,325,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,150,500 | 8,325,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,913,675 | 8,784,813 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $30,846,000 | 9,700,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $23,600,000 | 10,000,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $34,700,000 | 10,000,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $73,300,000 | 10,000,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $86,599,820 | 13,282,181 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $67,075,014 | 13,282,181 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $102,804,080 | 13,282,181 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $196,576,278 | 13,282,181 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $215,702,619 | 13,282,181 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||